Does taking an angiotensin inhibitor increase the risk for COVID-19? – a systematic review and meta-analysis

Because SARS-COV2 entry into cells is dependent on angiotensin converting enzyme 2 (ACE2) and angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) increase ACE2 activity, the safety of ACEI/ARB usage during the coronavirus disease 2019 (COVID-19) pandemic is a con...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zheng, Wang, Mei-Ping, Liu, Lian, Yu, Shuang, Wu, Tian-Ran, Zhao, Lei, Zhang, Ye-Ping, Liang, Hai-Feng, Yang, Xin-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109111/
https://www.ncbi.nlm.nih.gov/pubmed/33886504
http://dx.doi.org/10.18632/aging.202902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109111/
https://www.ncbi.nlm.nih.gov/pubmed/33886504
http://dx.doi.org/10.18632/aging.202902

Ejemplares similares